Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOLBusiness Wire • 06/20/25
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSRBusiness Wire • 06/03/25
Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye DiseaseBusiness Wire • 05/28/25
Turkey Contact Lens Market - Competition, Forecast & Opportunities to 2030, Featuring Tech Contactlens, Diafarma, Alcon Laboratories, Diplomat Optics, Hoya Turkiye, ZEISS Turkiye, Keralens & moreGlobeNewsWire • 05/26/25
Alcon Q1 Earnings Miss Estimates, Stock Down, 2025 EPS View LoweredZacks Investment Research • 05/14/25
Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionBenzinga • 05/14/25
Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCSBusiness Wire • 05/13/25
Ahead of Alcon (ALC) Q1 Earnings: Get Ready With Wall Street Estimates for Key MetricsZacks Investment Research • 05/08/25
Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CSBusiness Wire • 04/25/25
Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light ScatterBusiness Wire • 04/02/25
3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy SpaceZacks Investment Research • 03/31/25
Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial DiseaseBusiness Wire • 03/26/25
Alcon Stock Might Rise as Clareon Vivity IOL Secures CE Mark ApprovalZacks Investment Research • 03/25/25
Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual PossibilitiesBusiness Wire • 03/25/25
Retinal Surgery Devices Market Outlook Report 2025-2033: Revenues Set to Double, Reaching $4.83 Billion by 2033, Led by Topcon Corp., Alcon, and Carl ZeissGlobeNewsWire • 03/24/25